瘤微生物组:瘤启动,进展和治疗中的作用
Shengxin Zhang1, Jing Huang2, Zedong Jiang1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.
Molecular biomedicine
|February 8, 2025
概括
瘤微生物组显著影响癌症的发病,进展和转移. 准这些微生物为改善癌症治疗结果提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微生物组,包括内微生物,在瘤微环境 (TME) 中发挥着关键作用.
- 了解瘤微生物组的功能对于开发新型癌症疗法和提高治疗疗效至关重要.
研究的目的:
- 审查与瘤相关的微生物群落的起源,组成和多样性.
- 阐明瘤微生物群影响癌症发病,进展,转移和耐药性的机制.
- 探索基于微生物的创新治疗策略,用于癌症治疗.
主要方法:
- 文献综述总结了关于瘤微生物组的当前研究.
- 对16S核糖体核糖核酸 (16SrRNA) 测序数据进行分析,用于内微生物组的表征.
- 综合了关于微生物在致癌,瘤进展,转移和治疗反应中的作用的发现.
主要成果:
- 瘤微生物组在各种癌症类型和癌症阶段表现出多样化的组成.
- 特定的微生物通过致癌途径,DNA损伤,表观遗传变化和炎症促进瘤的开始.
- 瘤微生物群通过免疫逃避和促进血管生成影响瘤的进展,并在多个阶段影响转移.
- 瘤微生物组的组成与耐药性有关,并通过免疫反应,新陈代谢和亡来调节治疗疗效.
结论:
- 瘤微生物组是癌症发展和进展的关键参与者.
- 向瘤微生物组为新型癌症治疗提供了有希望的途径.
- 基于微生物的策略,包括工程细菌和病毒疗法,可以增强免疫治疗的疗效,并导致以微生物为中心的癌症治疗框架.
更多相关视频
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
10.2K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
